Four years after gaining FDA approval for Auvelity to treat major depressive disorder (MDD), Axsome Therapeutics has tacked on a second nod in the United States for the first-in-class medicine to treat agitation associated with dementia caused by Alzheimer’s disease.

The agency’s decision marks the first approval of a drug with this specific mechanism of action for one of the most burdensome and clinically challenging symptoms of the disease.

Providers of mental health support and families of patients fear the dire consequences that will come from changes to insurance coverage

Up to 76% of patients with Alzheimer’s disease experience agitation, including pacing, restlessness and verbal or physical aggression.

Two guests who stayed at Wynn Las Vegas contracted Legionnaires’ disease, a severe type of pneumonia, in separate instances.

Organizers said mental health will be a key focus of the summit.

An eye mask, earplugs, and a same-day workout can all increase your odds.

On the morning of March 20, medical students at UNLV’s Kirk Kerkorian School of Medicine gathered with their families in a room buzzing with nervous energy. At noon Eastern time, along with tens of thousands of peers at medical schools across the country, they tore open envelopes to learn where they would spend the next three to seven years of their lives — and, in many cases, build their entire careers.

A study examining whether the Covid-19 vaccine was keeping adults from becoming sick enough to have to go to the hospital is no more.

The mayor said the district continues to grow as UNLV’s School of Medicine and School of Dentistry expand, creating a need for more housing for medical students.

The newest of these semi-local developments is the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio diagnostic test, which is the first test of its kind to diagnose Alzheimer's via blood samples. UNLV's Kirk Kerkorian School of Medicine contributed research to the test, which the FDA approved last year.

Heart disease remains the leading cause of death in the U.S., but its impact isn’t equal across communities. African Americans are significantly more likely to die from heart disease—even though many have similar or lower cholesterol levels. So, what’s driving this gap, and what can be done to close it?